Mielóma multiplex: vizsgálatok itt: Egyesült Államok
297 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Életkor
- 18 év and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - 1/2. fázisTaking peopleA Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Atlanta, Birmingham, Boston, Charlotte, Milwaukee, Nashville, New York, Philadelphia, San Francisco
- Életkor
- 18 év and over
- People
- 190
- Run by
- ModernaTX, Inc.
See details and how to joinNCT07116616 - 2. fázisTaking peopleTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Where
- Albuquerque, Allentown, Altamonte Springs, Ann Arbor, Atlanta, Auburn, Augusta, Aventura, Belfast, Berkeley, Bethlehem, Biddeford, Birmingham, Bismarck, Bluffton, Bonita Springs, Bonney Lake, Bradenton, Brandon, Brewer, Bridgeport, Brunswick, Burlington, Cape Coral, Cedar City, Chapel Hill, Charlotte, Chicago, Cincinnati, Clearwater, Concord, Coral Gables, Deerfield Beach, Detroit, East Stroudsburg, ‘Ewa Beach, Fairfax, Fargo, Federal Way, Flint, Fort Lauderdale, Fort Myers, Gainesville, Germantown, Gig Harbor, Grafton, Grand Rapids, Green Bay, Hartford, Hazleton, Hilton Head Island, Honolulu, Houston, Indianapolis, Kennebunk, Kenosha, Kettering, Kittery, Lake Success, Lansing, Largo, Las Cruces, Lecanto, Livonia, Los Angeles, Manchester, Marinette, Meriden, Miami, Milwaukee, Mount Kisco, Naples, Nashville, New Britain, New Hyde Park, New York, Norway, Norwich, Oakland, Ocala, Olympia, Omaha, Orange City, Orlando, Oshkosh, Palo Alto, Philadelphia, Phoenix, Plantation, Pontiac, Port Charlotte, Portland, Portsmouth, Puyallup, Racine, Rego Park, Rio Rancho, Rockport, Roseville, Sacramento, Saginaw, Salt Lake City, Sanford, San Francisco, San Jose, San Leandro, Santa Barbara, Santa Clara, Santa Cruz, Sarasota, Savannah, Scarborough, Seattle, Sheboygan, Sioux Falls, Sleepy Hollow, South Portland, St. George, St. Petersburg, Summit, Sunnyvale, Tacoma, Tampa, Tavares, The Villages, Topsham, Torrington, Traverse City, Trinity, Two Rivers, Vallejo, Venice, Walnut Creek, Warren, Wauwatosa, Wells, West Chester, Willimantic, Winter Park, York Village
- Életkor
- 12 év and over
- People
- 4200 worldwide
- Run by
- American Society of Clinical Oncology
See details and how to joinNCT02693535 - 2. fázisCsak meghívásosLong-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
- Where
- Austin, Miami, St Louis
- Életkor
- 1 év and over
- People
- 500 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT03628612 - 1. fázisTaking peopleCarfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
- Where
- Hackensack
- Életkor
- 18 év and over
- People
- 18
- Run by
- Hackensack Meridian Health
See details and how to joinNCT03909412 - 2. fázisTaking peopleA Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
- Where
- Hackensack, Washington D.C.
- Életkor
- 18 év and over
- People
- 96
- Run by
- Hackensack Meridian Health
See details and how to joinNCT04661137 - 2. fázisTaking peopleERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)
- Where
- Miami
- Életkor
- 18 év and over
- People
- 104
- Run by
- University of Miami
See details and how to joinNCT06997081 - 2. fázisTaking peopleInobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Where
- Ann Arbor, Atlanta, Bethesda, Boston, Charlotte, Chicago, Cleveland, Hackensack, Iowa City, Jacksonville, Milwaukee, New Brunswick, Omaha, Philadelphia, Phoenix, Rochester, San Francisco, Seattle, St Louis, Tampa, Winston-Salem
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT07096778 - 1. fázisTaking peopleA Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Rochester
- Életkor
- 18 év and over
- People
- 40
- Run by
- Vyriad, Inc.
See details and how to joinNCT07802717 - 2. fázisTaking peopleA Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"
- Where
- Houston
- People
- 34
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07382739 - 1/2. fázisTaking peopleStudy to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- Where
- Atlanta, Houston, Louisville, New York, Omaha
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Heidelberg Pharma AG
See details and how to joinNCT04879043 · EU 2024-515273-10-00 - 1. fázisTaking peopleImaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 20
- Run by
- Robert Flavell, MD, PhD
See details and how to joinNCT05892393 - 2. fázisTaking peopleELISA in Relapsed/Refractory MM
- Where
- Boston
- Életkor
- 18 év and over
- People
- 30
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06832865 - 1/2. fázisTaking peopleResponse-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07181941 - No phaseTaking peopleDevelopment of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
- Where
- Sacramento
- Életkor
- 21 év and over
- People
- 4000
- Run by
- University of California, Davis
See details and how to joinNCT04314752 - 2. fázisTaking peopleSubcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
- Where
- New York
- Életkor
- 70 év and over
- People
- 23
- Run by
- Larysa Sanchez
See details and how to joinNCT06827860 - 2. fázisTaking peopleA Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Columbia, Denver, Eugene, Las Vegas, Nashville
- Életkor
- 18 év and over
- People
- 46
- Run by
- SCRI Development Innovations, LLC
See details and how to joinNCT07637578 - 2. fázisTaking peopleBelantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 34
- Run by
- Emory University
See details and how to joinNCT05208307 - 2. fázisTaking peopleHCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
- Where
- Durham
- Életkor
- 18 év and over
- People
- 27
- Run by
- Duke University
See details and how to joinNCT06822972 - 1/2. fázisNot yet taking people in Egyesült ÁllamokIsatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
- Where
- Boston
- Életkor
- 18 év and over
- People
- 88
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07601100 - 1/2. fázisTaking peopleA Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
- Where
- Birmingham, Hackensack, Houston, New Haven
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Celgene
See details and how to joinNCT06988488 · EU 2025-522090-11-00 - 2. fázisNot yet taking people in Egyesült ÁllamokMMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
- Where
- Little Rock
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- University of Arkansas
See details and how to joinNCT07029776 - 2. fázisTaking peopleElranatamab in R/R Multiple Myeloma
- Where
- Boston
- Életkor
- 18 év and over
- People
- 32
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06138275 - 1/2. fázisTaking peopleStudy of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
- Where
- Madison
- Életkor
- 18 év and over
- People
- 62
- Run by
- Natalie Callander
See details and how to joinNCT07479979 - 2. fázisTaking peoplePost-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
- Where
- Chicago, Salt Lake City
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Illinois Chicago
See details and how to joinNCT05344833